Said Moshawih | Pharmacology | Best Researcher Award

Published on by Health Scientists
Said Moshawih
Affiliation Al-Ahliyya Amman University
Country Jordan
Scopus ID 57209745538
Documents 42
Citations 998
h-index
17
Subject Area Pharmacology
Event Health Scientists Awards
ORCID 0000-0003-4840-0460

Best Researcher Award

Said Moshawih is an academic researcher specializing in pharmacology, medicinal plants, natural products, phytochemistry, pharmaceutical sciences, and evidence-based herbal medicine. His research integrates laboratory investigations with systematic scientific reviews to evaluate bioactive compounds, therapeutic mechanisms, and translational healthcare applications. His scholarly publications have contributed to understanding herbal pharmacology, cardiovascular protection, antimicrobial activities, antioxidant mechanisms, and functional medicinal plants while supporting innovation in pharmaceutical research and healthcare advancement.[1]

Abstract

Said Moshawih has established an internationally recognized research portfolio in pharmacology through multidisciplinary investigations involving medicinal plants, phytochemistry, pharmaceutical sciences, cardiovascular health, antimicrobial agents, antioxidant compounds, and evidence-based herbal medicine. His publications emphasize translating traditional medicinal knowledge into scientifically validated therapeutic applications while encouraging sustainable healthcare innovation. Through collaborations, systematic reviews, experimental pharmacology, and natural product research, his work has strengthened pharmaceutical development, improved understanding of bioactive compounds, supported clinical relevance, and contributed valuable scientific evidence for advancing modern healthcare practices and future pharmacological discoveries.[2]

Keywords

Medicinal plants, Pharmacology, Phytochemistry, Herbal medicine, Natural products, Antioxidants, Cardiovascular health, Antimicrobial activity, Ethnopharmacology, Functional foods, Bioactive compounds, Pharmaceutical sciences, Toxicology, Drug discovery, Plant extracts.

Introduction

Said Moshawih investigates medicinal plants and pharmaceutical sciences by integrating pharmacological evidence with phytochemical characterization. His research supports safe therapeutic development, explores natural bioactive compounds, and promotes evidence-based herbal medicine for improving disease prevention, healthcare quality, and future pharmaceutical innovation through multidisciplinary scientific collaboration worldwide.[3]

Research Profile

Said Moshawih maintains an active international research profile with publications spanning pharmacology, medicinal chemistry, pharmaceutical technology, herbal therapeutics, and systematic scientific reviews. His collaborative investigations have generated influential literature supporting translational medicine while encouraging innovation across academic, clinical, and pharmaceutical research environments globally.[1]

Research Contributions

Said Moshawih has contributed significantly to understanding phytochemicals, herbal pharmacology, antioxidant mechanisms, cardiovascular protection, antimicrobial compounds, and pharmaceutical formulations. His research strengthens scientific validation of medicinal plants while encouraging interdisciplinary collaborations that bridge laboratory discoveries with practical healthcare applications and therapeutic innovations.[4]

Publications

Said Moshawih has authored numerous highly cited publications covering medicinal plants, coriander pharmacology, herbal cardiovascular benefits, antimicrobial phytochemicals, colorectal cancer prevention, pharmaceutical sciences, and evidence-based natural medicine. These publications demonstrate sustained scholarly productivity, interdisciplinary collaboration, and consistent contributions to international scientific literature.[2]

Research Impact

Said Moshawih’s research has influenced pharmaceutical sciences by providing comprehensive evidence supporting medicinal plants and natural therapeutics. His publications receive substantial academic recognition through citations, demonstrating meaningful impact on pharmacological research, healthcare innovation, systematic reviews, and future evidence-based therapeutic development internationally.[1]

Award Suitability

Said Moshawih demonstrates strong qualifications for the Best Researcher Award through impactful publications, substantial citation performance, international collaborations, and continuous advancement of pharmacological knowledge. His scientific achievements reflect excellence in research quality, innovation, scholarly influence, and contributions benefiting healthcare and pharmaceutical sciences.[1]

Conclusion

Said Moshawih continues advancing pharmacology through innovative investigations involving medicinal plants, pharmaceutical sciences, and natural products. His sustained scholarly productivity, collaborative research, and evidence-based scientific contributions reinforce his reputation as a respected researcher supporting future developments in healthcare, therapeutic innovation, and pharmaceutical research worldwide.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Said Moshawih, Author ID 57209745538. Scopus.
    https://www.scopus.com/pages/authors/57209745538
  2. ResearchGate. (n.d.). Research Profile of Said Moshawih.
    https://www.researchgate.net/profile/Said-Moshawih
  3. ORCID. Said Moshawih Research Profile.
    https://orcid.org/0000-0003-4840-0460
  4. Google Scholar. Said Moshawih Citation Profile.
    https://scholar.google.com/citations?user=_eqg7H4AAAAJ&hl=en&oi=ao
  5. Al-Ahliyya Amman University. Faculty Profile: Said Moshawih.
    https://www.ammanu.edu.jo/staff-directory/faculty-of-pharmacy/said-moshawih/

Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Featured Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Published on by Health Scientists

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Featured Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Featured Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.